FLAVONE
FLAVONE is a lipid of Polyketides (PK) class. Flavone is associated with abnormalities such as Cardiovascular Diseases, Cerebrovascular accident, DERMATITIS HERPETIFORMIS, FAMILIAL, Hyperinsulinism and Inflammatory disorder. The involved functions are known as Oxidation-Reduction, Metabolic Inhibition, Inflammation, Phosphorylation and antioxidant activity. Flavone often locates in Endothelium, Hepatic, Protoplasm, Body tissue and Extracellular. The associated genes with FLAVONE are ICAM1 gene, BCL2L1 gene, MYC gene, TP53 gene and cytochrome c''. The related lipids are Promega, Steroids and Total cholesterol. The related experimental models are Knock-out, Disease model and Animal Disease Models.
Cross Reference
Introduction
To understand associated biological information of FLAVONE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with FLAVONE?
FLAVONE is suspected in Diabetes Mellitus, Non-Insulin-Dependent, Obesity, Chronic Disease, Disintegration, Cardiovascular Diseases, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with FLAVONE
PubChem Associated disorders and diseases
What pathways are associated with FLAVONE
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with FLAVONE?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with FLAVONE?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with FLAVONE?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with FLAVONE?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with FLAVONE?
Knock-out
Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011) and Knock-out are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).
Disease model
Disease model are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).
Animal Disease Models
Animal Disease Models are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with FLAVONE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cai H et al. | Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties. | 2007 | Cancer Chemother. Pharmacol. | pmid:17089164 |
| Cummings J and Smyth JF | Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours. | 1989 | Cancer Chemother. Pharmacol. | pmid:2667786 |
| Chabot GG et al. | Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice. | 1989 | Cancer Chemother. Pharmacol. | pmid:2597279 |
| Thomas JP et al. | Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol. | 2002 | Cancer Chemother. Pharmacol. | pmid:12451473 |
| Cassidy J et al. | Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients? | 1989 | Cancer Chemother. Pharmacol. | pmid:2713962 |
| Chabot GG et al. | Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro. | 1989 | Cancer Chemother. Pharmacol. | pmid:2758556 |
| Bibby MC et al. | Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512). | 1989 | Cancer Chemother. Pharmacol. | pmid:2731316 |
| Cai H et al. | Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3',4',5',5,7-pentamethoxyflavone and tricin (4',5,7-trihydroxy-3',5'-dimethoxyflavone). | 2011 | Cancer Chemother. Pharmacol. | pmid:20364427 |
| Verschoyle RD et al. | Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone. | 2006 | Cancer Chemother. Pharmacol. | pmid:16001171 |
| Enomoto R et al. | Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. | 2011 | Cancer Chemother. Pharmacol. | pmid:20658136 |
| Damia G et al. | Dose-dependent pharmacokinetics of flavone acetic acid in mice. | 1988 | Cancer Chemother. Pharmacol. | pmid:3396145 |
| Gouyette A et al. | Flavone acetic acid: a nonlinear pharmacokinetic model. | 1988 | Cancer Chemother. Pharmacol. | pmid:3409441 |
| O'Dwyer PJ et al. | Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent. | 1987 | Cancer Chemother. Pharmacol. | pmid:3545524 |
| Weiss GR et al. | New anticancer agents. | 1988 | Cancer Chemother Biol Response Modif | pmid:2484323 |
| Weiss GR et al. | New anticancer agents. | 1987 | Cancer Chemother Biol Response Modif | pmid:2484330 |
| Lagiou P et al. | Flavonoid intake and liver cancer: a case-control study in Greece. | 2008 | Cancer Causes Control | pmid:18350370 |
| Hirvonen T et al. | Flavonol and flavone intake and the risk of cancer in male smokers (Finland). | 2001 | Cancer Causes Control | pmid:11714106 |
| Büchner FL et al. | Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). | 2010 | Cancer Causes Control | pmid:19924549 |
| Li YR et al. | Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo. | 2016 | Cancer Biol. Ther. | pmid:26569090 |
| McKeage MJ and Baguley BC | Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer. | 2010 | Cancer | pmid:20166210 |
| Cavé A et al. | [Pachypodol (5,4'-dihydroxy 3,7,3'-trimethoxy flavone or 3,7,3'-quercetol trimethylether), a new flavonoid isolated from Pachypodanthium confine Engler and Diels (annonaceae)]. | 1973 | C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. | pmid:4201538 |
| Quéval P and Beaumatin J | [Study of the inductor effect of 5,6-benzoflavone on the activity of pulmonary benzopyrene monoxidase. Comparison with other chemical or physical agents]. | 1979 | C. R. Acad. Sci., D, Sci. Nat. | pmid:111845 |
| Li G et al. | Effects of elevated CO(2) and O(3) on phenolic compounds in spring wheat and maize leaves. | 2008 | Bull Environ Contam Toxicol | pmid:18781273 |
| Bonnay M et al. | [Flavone acetic acid and LY 186641 interfere in various ways in Jaffé's reaction]. | 1989 | Bull Cancer | pmid:2620109 |
| Tranchand B et al. | [Phase I pharmacokinetics of flavone-acetic acid]. | 1989 | Bull Cancer | pmid:2620114 |
| Atkinson C et al. | Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. | 2004 | Breast Cancer Res. | pmid:15084240 |
| Androutsopoulos V et al. | Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. | 2008 | Breast Cancer Res. | pmid:18454852 |
| Zeng Y et al. | Baicalin reduces the severity of experimental autoimmune encephalomyelitis. | 2007 | Braz. J. Med. Biol. Res. | pmid:17653455 |
| Ono M | [Molecular imaging of beta-amyloid plaques in the brain]. | 2007 | Brain Nerve | pmid:17370649 |
| Hadjokas NE et al. | Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells. | 2002 | Br. J. Pharmacol. | pmid:12023936 |
| Kavvadias D et al. | The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. | 2004 | Br. J. Pharmacol. | pmid:15231642 |
| Mursu J et al. | Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. | 2008 | Br. J. Nutr. | pmid:18377681 |
| Leung LK et al. | Effect of dietary flavonols on oestrogen receptor transactivation and cell death induction. | 2004 | Br. J. Nutr. | pmid:15182386 |
| Pepper C et al. | Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia. | 2001 | Br. J. Haematol. | pmid:11472347 |
| Ching LM et al. | Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice. | 2004 | Br. J. Cancer | pmid:14970872 |
| Jameson MB et al. | Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent. | 2003 | Br. J. Cancer | pmid:12799625 |
| Rustin GJ et al. | 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study. | 2003 | Br. J. Cancer | pmid:12698178 |
| Zhao L et al. | The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice. | 2002 | Br. J. Cancer | pmid:12177785 |
| Jones DJ et al. | Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity. | 2004 | Br. J. Cancer | pmid:15292928 |
| Peterson J et al. | Flavonoid intake and breast cancer risk: a case--control study in Greece. | 2003 | Br. J. Cancer | pmid:14520456 |
| Cai H et al. | Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. | 2004 | Br. J. Cancer | pmid:15316567 |
| Kerr DJ et al. | Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. | 1989 | Br. J. Cancer | pmid:2803908 |
| Murray JC et al. | Flavone acetic acid induces a coagulopathy in mice. | 1989 | Br. J. Cancer | pmid:2803949 |
| Pratesi G et al. | Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512). | 1988 | Br. J. Cancer | pmid:3166904 |
| Bibby MC et al. | Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512). | 1988 | Br. J. Cancer | pmid:3179187 |
| Double JA et al. | Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon. | 1986 | Br. J. Cancer | pmid:3778803 |
| Bibby MC et al. | Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). | 1987 | Br. J. Cancer | pmid:3814485 |
| Newell DR et al. | Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK. | 2003 | Br. J. Cancer | pmid:12888809 |
| Giavazzi R et al. | Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts. | 1988 | Br. J. Cancer | pmid:3355765 |
| Hinnen P and Eskens FA | Vascular disrupting agents in clinical development. | 2007 | Br. J. Cancer | pmid:17375046 |